FrancophonIA/ELRC3.0 huggingface dataset:
English: Regarding the recommended dose, PK/PD-analysis is of limited value, considering that: - recent data on susceptibility and resistance of equine target pathogens are missing; - pharmacokinetic data do not allow proper comparison of the plasma concentration profiles in the horse over the dosing intervals and the entire treatment period depending on a once or twice daily dosing regimen.
Slovenian: - farmakokinetični podatki ne dovoljujejo primerne primerjave profilov plazemske koncentracije pri konjih v intervalih odmerjanja in celotnemu obdobju zdravljenja glede na to, ali gre za način odmerjanja enkrat ali dvakrat dnevno.
English: Each syringe contains one daily dose for a 500 kg horse.
Slovenian: Vsaka injekcijska brizga vsebuje en dnevni odmerek za 500 kg težkega konja.
English: 30mg of combined active ingredients per kg bodyweight daily.
Slovenian: 30 mg kombiniranih zdravilnih učinkovin na kg telesne mase dnevno.
English: Sulfadiazine 333 mg/g Trimethoprim 67 mg/g horses Bacterial infections, for instance infections in wounds, respiratory tract, GI-tract or urogenital system.
Slovenian: 67 mg/g konji Bakterijske okužbe, na primer okužbe ran, dihalnega trakta, gastrointestinalnega trakta ali urogenitalnega sistema.
English: The daily dose is 30 mg combined active ingredients per kg body weight.
Slovenian: Dnevni odmerek je 30 mg kombiniranih zdravilnih učinkovin na kg telesne mase.
English: The product may be effective in alimentary tract infection such as diarrhoea; respiratory infections including pneumonia, pleurisy, strangles; wounds, septicaemia and general infections.
Slovenian: Priporočeni odmerek diareja; okužbah dihal, vključno s pljučnico, plevritisom, okužbo s Streptococcus equi; ranah, septikemiji in splošnih okužbah.
English: Sulfadiazine 333 mg Trimethoprim 67 mg horses Bacterial infections, for instance infections in wounds, respiratory tract, GI-tract or urogenital system.
Slovenian: 67 mg konji Bakterijske okužbe, na primer okužbe ran, dihalnega trakta, gastrointestinalnega trakta ali urogenitalnega sistema.
English: The dose is reached by setting the drive screw on the plunger according to the weight of the horse.
Slovenian: Odmerek dobite tako, da vijak na batu nastavite skladno s maso konja.
English: Each syringe provides one daily dose for a 500 kg horse.
Slovenian: Vsaka injekcijska brizga da en dnevni odmerek za 500 kg težkega konja.
English: Each division on the plunger provides sufficient paste to medicate 50 kg bodyweight.
Slovenian: Vsak razdelek na batu da dovolj paste za zdravljenje 50 kg telesne mase.
English: Each syringe provides a daily dose for a 500 kg horse.
Slovenian: Vsaka injekcija da dnevni odmerek za 500 kg težkega konja.
English: Each division the dial-a-dose plunger provides sufficient medication to treat 50 kg of body weight.
Slovenian: Vsak razdelek na batu za nastavitev odmerka da dovolj zdravila za zdravljenje 50 kg telesne mase.
English: Trimethoprim 58 mg/g Sulfadiazine 288,3 mg/g horses Infections in horses caused by micro-organisms sensitive to trimethoprim + sulphonamide
Slovenian: 288,3 mg/g konji Okužbe pri konjih, ki jih povzročajo mikroorganizmi, občutljivi na trimetoprim + sulfonamid
English: Trimethoprim 2 mg
Slovenian: Peroralna pasta sulfadiazin 333 mg/g trimetoprim
English: - urogenital infections caused by bèta-haemolytic streptococci; - wounds and abscesses by Streptococcus spp., Staphylococcus aureus.
Slovenian: in Staphylococcus aureus; Okužbe prebavnega trakta, povezane z E. Coli; Okužbe urogenitalnega trakta, povezane z beta hemolitičnimi streptokoki; Okužbe ran in abscesov, povezane z bakterijama Streptococcus spp.
English: Treatment should be continued for up to 5 days or until 2 days after the symptoms have resolved.
Slovenian: Zdravljenje je treba izvajati do največ pet dni ali še dva dni po izginotju simptomov.
English: The daily dose is 30 mg of combined actives per kg bodyweight by oral administration.
Slovenian: Dnevni odmerek je 30 mg kombiniranih zdravilnih učinkovin na kg telesne mase z dajanjem po peroralni poti.
English: plunger provides sufficient paste to medicate 50 kg bodyweight.
Slovenian: nastavitev odmerka da dovolj zdravila za zdravljenje 50 kg telesne mase.
English: Trimethoprim 5.78%w/w Sulfadiazine 28.89% w/w horses Treatment of bacterial infections in horses caused by sensitive microorganisms including:
Slovenian: 28,89 % m/m konji Zdravljenje bakterijskih okužb pri konjih, ki jih povzročajo občutljivi mikroorganizmi, vključno z:
English: Corynebacterium equi Staphylococcus spp.
Slovenian: Staphylococcus spp.
English: The
Slovenian: Schering
English: 1 g contain: Sulfadiazine 288.3 mg horses Infections in horses caused by micro-organisms sensitive to trimetoprim + sulphonamide, e.g. infections in the airways, GI
Slovenian: sulfadiazin 288,3 mg trimetoprim 58,0 mg konji Okužbe pri konjih, ki jih povzročajo mikroorganizmi, občutljivi na trimetoprim + sulfonamid, tj. okužbe dihal, prebavil, urogenitalnega trakta in okužbe ran.
English: (See section 6.4.)
Slovenian: (Glejte poglavje 6.4.)
English: The effects of this change are anticipated to be transient.
Slovenian: Pričakuje se, da so vplivi te spremembe prehodni.
English: Date of first authorisation: 18 April 2002 Date of latest renewal: 22 December 2011
Slovenian: Datum prve odobritve: 18. april 2002 Datum zadnjega podaljšanja: 22. december 2011
English: The first 2 numbers indicate the month; the next 4 numbers indicate the year.
Slovenian: Prvi 2 številki pomenita mesec, naslednje 4 pa leto.
English: Species for which acquired resistance may be a problem:
Slovenian: Vrste pri katerih bi bila pridobljena odpornost lahko problem:
English: This is called overgrowth.
Slovenian: To se imenuje razraščanje.
English: The EUCAST MIC breakpoints are as follows:
Slovenian: Referenčne vrednosti EUCAST MIK so sledeče:
English: Therefore, caution should be exercised in such unusual cases.
Slovenian: V takšnih neobičajnih primerih je zato potrebna previdnost.
English: * Activity has been satisfactorily demonstrated in clinical studies.
Slovenian: * Aktivnost je bila zadostno dokazana v kliničnih študijah.
English: Solutions should be used within 4 hours of their removal from the refrigerator.
Slovenian: Raztopino je treba porabiti v 4 urah po tem, ko jo vzamete iz hladilnika.
English: Infuse over a period of 30 minutes.
Slovenian: Infundirajte 30 minut.
English: The overall safety profile is comparable to that in adult patients.
Slovenian: Celokupni varnostni profil je primerljiv s tistim pri odraslih bolnikih.
English: The first signs of a severe allergic reaction may include swelling of the face and/or throat.
Slovenian: Prvi znaki hude alergijske reakcije lahko vključujejo otekanje obraza in/ali žrela.
English: - Allergies to any medicines, including antibiotics.
Slovenian: - alergijami na katerokoli zdravilo, vključno z antibiotiki.
English: Similar observations have been made in the post-marketing environment.
Slovenian: Do podobnih opažanj so prišli tudi v obdobju trženja zdravila.
English: Commonly susceptible species:
Slovenian: Običajno občutljive vrste:
English: Serious anaphylactic reactions require immediate emergency treatment.
Slovenian: Hude anafilaktične reakcije zahtevajo takojšnje nujno zdravljenje.
English: Your doctor has prescribed INVANZ because you or your child has one (or more) of the following types of infection:
Slovenian: Zdravnik je vam ali vašemu otroku predpisal zdravilo INVANZ, ker imate enega (ali več) od naslednjih tipov okužb:
English: Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥ 1/10,000 to < 1/1,000); Very rare (< 1/10,000); Not known (cannot be estimated from the available data)
Slovenian: Pogosti ( 1/100 do  1/10); občasni (≥ 1/1.000 do  1/100); redki (≥ 1/10.000 do  1/1.000); zelo redki ( 1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov)
English: If an allergic reaction to ertapenem occurs (see section 4.8), discontinue the therapy immediately.
Slovenian: Če se pojavi alergijska reakcija na ertapenem (glejte poglavje 4.8), takoj prekinite zdravljenje.
English: Adequate and well-controlled studies have not been performed in pregnant women.
Slovenian: Ustreznih in dobro kontroliranih študij pri nosečnicah niso izvedli.
English: These reactions are more likely to occur in individuals with a history of sensitivity to multiple allergens.
Slovenian: Te reakcije so verjetnejše pri posameznikih z anamnezo preobčutljivosti za več alergenov.
English: In Escherichia coli, affinity is strongest to PBPs 2 and 3.
Slovenian: Pri Escherichii coli je afiniteta najmočnejša za PVB 2 in 3.
English: It has the ability to kill a wide range of bacteria (germs) that cause infections in various parts of the body.
Slovenian: Uniči lahko širok spekter bakterij (klic), ki povzročajo okužbe v različnih delih telesa.
English: Repeated evaluation of the patient's condition is essential.
Slovenian: Večkrat je treba oceniti bolnikovo stanje.
English: 3 to 23 months 31/35 88.6 13/13 100.0
Slovenian: 3 do 23 mesecev 31/35 88,6 13/13 100,0 2 do 12 let
English: • decreased consciousness
Slovenian: • zmanjšana stopnja zavesti,
English: Efficacy in Paediatric Studies
Slovenian: Učinkovitost v pediatričnih študijah
English: Based on the data available it cannot be excluded that in the few cases of surgical interventions exceeding 4 hours, patients could be exposed to sub-optimal ertapenem concentrations and consequently to a risk of potential treatment failure.
Slovenian: Glede na podatke, ki so na voljo, ni moč izključiti, da so v redkih primerih kirurške intervencije, ki presega 4 ure, bolniki lahko izpostavljeni suboptimalnim koncentracijam ertapenema in je zato tveganje za neuspešnost zdravljenja večja.
English: Your doctor will monitor you for overgrowth and treat you if necessary.
Slovenian: Vaš zdravnik vas bo spremljal zaradi morebitnega razraščanja in vas po potrebi zdravil.
English: INVANZ can be given to persons 3 months of age and older.
Slovenian: Zdravilo INVANZ se lahko daje osebam, starim 3 mesece ali več.
English: If these symptoms occur tell your doctor straight away as you may need urgent medical treatment.
Slovenian: Če se pojavijo ti simptomi, to takoj povejte zdravniku, ker boste morda potrebovali nujno medicinsko oskrbo.
English: Therefore, ertapenem should not be used in these patients.
Slovenian: Zato se ertapenema pri teh bolnikih ne sme uporabljati.
English: If superinfection occurs during therapy, appropriate measures should be taken.
Slovenian: Če med zdravljenjem pride do superinfekcije, je treba primerno ukrepati.
English: What INVANZ is and what it is used for
Slovenian: Kaj je zdravilo INVANZ in za kaj ga uporabljamo
English: While antibiotics including INVANZ kill certain bacteria, other bacteria and fungi may continue to grow more than normal.
Slovenian: Medtem ko antibiotiki, vključno z zdravilom INVANZ, uničijo določene bakterije, lahko druge bakterije in glive rastejo bolj kot običajno.
English: Microbiological susceptibility
Slovenian: Mikrobiološka občutljivost
English: EU/1/02/216/001 1 vial EU/1/02/216/002 10 vials
Slovenian: EU/1/02/216/001 1 viala EU/1/02/216/002 10 vial
English: The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections.
Slovenian: Prevalenca pridobljene odpornosti se lahko pri posameznih bakterijskih vrstah geografsko in časovno spreminja, zato je zaželeno pridobiti lokalne informacije o odpornosti, zlasti pri zdravljenju hudih okužb.
English: Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Slovenian: Upoštevati moramo uradne smernice za uporabo protibakterijskih učinkovin.
English: Do not use this medicine after the expiry date which is stated on the container.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
English: The proportion of patients with a favourable clinical response assessment at posttreatment visit in the clinical MITT population is shown below:
Slovenian: Delež bolnikov z ugodnim kliničnim odzivom ob obisku po zaključku zdravljenja v klinični MITT populaciji je prikazan v spodnji tabeli:
English: Information from clinical studies
Slovenian: Informacije iz kliničnih študij
English: INVANZ will always be prepared and given to you intravenously (into a vein) by a doctor or another healthcare professional.
Slovenian: Zdravilo INVANZ bo vedno pripravil in vam ga dal intravensko (v žilo) zdravnik ali drug zdravstveni delavec.
English: Prevention
Slovenian: Preventiva
English: Considerations for use in particular populations
Slovenian: Pozornost pri uporabi pri posebnih skupinah ljudi
English: • Skin infections of the foot in diabetic patients.
Slovenian: • okužbe kože diabetične noge pri diabetičnih bolnikih.
English: Uncommon: Positive Clostridium difficile toxin
Slovenian: Občasni: pozitiven toksin Clostridium difficile
English: It is very important that you continue to receive INVANZ for as long as your doctor prescribes it.
Slovenian: Zelo pomembno je, da zdravilo INVANZ dobivate tako dolgo, kot vam predpiše zdravnik.
English: Diluted solutions should be used immediately.
Slovenian: Razredčeno raztopino je treba uporabiti takoj.
English: Ertapenem was evaluated primarily for paediatric safety and secondarily for efficacy in randomised comparative, multicentre studies in patients 3 months to 17 years of age.
Slovenian: Ertapenem so ocenjevali primarno z namenom presoje pediatrične varnosti in sekundarno z namenom presoje učinkovitosti v randomiziranih, primerjalnih, multicentričnih študijah pri bolnikih, starih od 3 mesecev do 17 let.
English: Bacteroides fragilis and species in the B. fragilis Group* Inherently resistant organisms:
Slovenian: Bacteroides fragilis in vrste iz skupine B. fragilis* Naravno odporni povzročitelji:
English: In this age group your doctor will decide on the potential benefit of its use.
Slovenian: V tej starostni skupini bo zdravnik presodil o možni koristi zdravljenja.
English: Therefore, ertapenem should not be used in these patients (see section 5.2.).
Slovenian: Zato se ertapenema pri teh bolnikih ne sme uporabljati (glejte poglavje 5.2).
English: Your doctor will decide whether you should use INVANZ in combination with these other medicines.
Slovenian: Zdravnik se bo odločil, ali boste prejemali zdravilo INVANZ skupaj s temi zdravili.
English: Ertapenem Ticarcillin/clavulanate n/m % n/m %
Slovenian: Starost ertapenem tikarcilin/klavulana n/m % n/m %
English: The safety and efficacy of INVANZ in children below 3 months of age have not yet been established.
Slovenian: Varnost in učinkovitost zdravila INVANZ pri otrocih, starih manj kot 3 mesece, še nista bili dokazani.
English: The usual duration of therapy with INVANZ is 3 to 14 days but may vary depending on the type and severity of infection and causative pathogen(s).
Slovenian: Običajno trajanje zdravljenja z zdravilom INVANZ je 3 do 14 dni, vendar je lahko različno glede na tip in resnost okužbe ter njenega povzročitelja (povzročiteljev).
English: This includes 9 patients in the ertapenem group (7 CAP and 2 IAI), 2 patients in the ceftriaxone group (2 CAP), and 1 patient with IAI in the ticarcillin/clavulanate group with secondary bacteraemia at entry into the study.
Slovenian: Vključuje 9 bolnikov v skupini z ertapenemom (7 CAP in 2 IAI), 2 bolnika v skupini s ceftriaksonom (2 CAP) in 1 bolnika z IAI v skupini s tikarcilinom/klavulansko kislino s sekundarno bakteriemijo pri vstopu v študijo.
English: • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
Slovenian: • Preobčutljivost na učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1.
English: Community Acquired Pneumonia (CAP)
Slovenian: Zunajbolnišnična pljučnica (Community Acquired Pneumonia - CAP)
English: In vitro studies in human liver microsomes indicate that ertapenem does not inhibit metabolism mediated by any of the six major CYP isoforms: 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4.
Slovenian: In vitro študije človeških jetrnih mikrosomov kažejo, da ertapenem ne zavira presnove z nobeno od šestih glavnih izooblik CYP: 1A2, 2C9, 2C19, 2D6, 2E1 in 3A4.
English: Concomitant use with valproic acid
Slovenian: Sočasna uporaba z valprojsko kislino
English: Tell your doctor about any medical condition you have or have had including: - Kidney disease.
Slovenian: Zdravnika seznanite z vsemi zdravstvenimi težavami, ki jih imate ali ste jih imeli, vključno z: - boleznijo ledvic.
English: If not used immediately, in use storage times are the responsibility of the user.
Slovenian: Če se raztopina ne uporabi takoj, je za čas do uporabe odgovoren uporabnik.
English: • Hypersensitivity to any other carbapenem antibacterial agent
Slovenian: • Preobčutljivost za kateri koli drug karbapenemski antibiotik.
English: Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryo-foetal development, parturition or post-natal development.
Slovenian: Študije na živalih ne kažejo posrednih ali neposrednih škodljivih učinkov na nosečnost, razvoj zarodka in ploda, porod ali poporodni razvoj.
English: During treatment, if you experience an allergic reaction (such as swelling of the face, tongue or throat, difficulty in breathing or swallowing, skin rash), tell your doctor straight away as you may need urgent medical treatment.
Slovenian: Če se med zdravljenjem pri vas pojavi alergijska reakcija (kot so otekanje obraza, jezika ali žrela, težave z dihanjem ali s požiranjem, izpuščaj na koži), takoj obvestite zdravnika, ker boste morda potrebovali nujno medicinsko oskrbo.
English: INVANZ is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4.4 and 5.1):
Slovenian: Zdravilo INVANZ je indicirano pri pediatričnih bolnikih (starih od 3 mesecev do 17 let) in odraslih za zdravljenje naslednjih okužb, če jih povzročajo bakterije, ki so ali ki so zelo verjetno občutljive za ertapenem, in kadar je potrebno parenteralno zdravljenje (glejte poglavji 4.4 in 5.1):
English: There have also been reports of changes in some laboratory blood tests.
Slovenian: Poročali so tudi o spremembah nekaterih laboratorijskih izvidov krvi.
English: Investigations Chemistry
Slovenian: Preiskave Kemijske
English: If you experience raised or fluid-filled skin spots over a large area of your body, tell your doctor or nurse straight away.
Slovenian: Če se pri vas pojavijo dvignjeni ali s tekočino napolnjeni kožni izpuščaji po večji površini vašega telesa, takoj obvestite zdravnika ali medicinsko sestro.
English: Pharmacotherapeutic group: Antibacterials for systemic use, carbapenems, ATC code: J01DH03
Slovenian: Farmakoterapevtska skupina: Zdravila za sistemsko zdravljenje bakterijskih infekcij, karbapenemski antibiotiki, oznaka ATC: J01DH03
English: Intravenous administration: INVANZ should be infused over a period of 30 minutes.
Slovenian: Intravenska uporaba: Zdravilo INVANZ je treba infundirati 30 minut.
English: Preclinical studies do not indicate direct or indirect harmful effects with respect to fertility (see section 5.3).
Slovenian: Predklinične študije ne kažejo neposrednih ali posrednih škodljivih učinkov na plodnost (glejte poglavje 5.3).
English: What you need to know before you are given INVANZ
Slovenian: Kaj morate vedeti, preden boste dobili zdravilo INVANZ
English: Discontinuation of therapy with INVANZ and the administration of specific treatment for Clostridium difficile should be considered.
Slovenian: Treba je razmisliti o prekinitvi zdravljenja z zdravilom INVANZ in specifičnem zdravljenju za Clostridium difficile.
English: There are no data in children and adolescents with renal impairment.
Slovenian: Podatkov za otroke in mladostnike z okvaro ledvic ni.
English: Ertapenem can be removed to some extent by haemodialysis (see section 5.2); however, no information is available on the use of haemodialysis to treat overdose.
Slovenian: Ertapenem se v določeni meri lahko odstrani s hemodializo (glejte poglavje 5.2), nimamo pa podatkov o uporabi hemodialize za zdravljenje prevelikega odmerjanja.
English: Common: Elevations in ALT and AST
Slovenian: Pogosti: zvišanje vrednosti ALT in AST
English: The concomitant use of ertapenem and valproic acid/sodium valproate is not recommended (see section 4.5).
Slovenian: Sočasne uporabe ertapenema in valprojske kisline/natrijevega valproata ne priporočamo (glejte poglavje 4.5).
English: The mechanism of action of ertapenem differs from that of other classes of antibiotics, such as quinolones, aminoglycosides, macrolides and tetracyclines.
Slovenian: Mehanizem delovanja ertapenema je drugačen kot pri drugih razredih antibiotikov, kot so kinoloni, aminoglikozidi, makrolidi in tetraciklini.
English: Justification for not including Braille accepted.
Slovenian: Sprejeta je utemeljitev, da Braillova pisava ni potrebna
English: However, in the event of an overdose, treatment with INVANZ should be discontinued and general supportive treatment given until renal elimination takes place.
Slovenian: Vendar pa je treba v primeru prevelikega odmerjanja zdravljenje z zdravilom INVANZ prekiniti in uvesti splošno podporno zdravljenje, dokler se zdravilo ne izloči skozi ledvice.
English: 15 mL Type I glass vials with a grey butyl stopper and a white plastic cap on a coloured aluminium band seal.
Slovenian: 15 ml viala iz stekla tipa I s sivim zamaškom iz butilne gume in belim plastičnim pokrovčkom na barvnem aluminijastem obročku.
English: F-63963 Clermont-Ferrand Cedex 9, France.
Slovenian: F-63963 Clermont-Ferrand Cedex 9, Francija.
English: Seizures occurred most commonly in elderly patients and those with pre-existing central nervous system (CNS) disorders (e.g. brain lesions or history of seizures) and/or compromised renal function.
Slovenian: Epileptični napadi so se najpogosteje pojavili pri starejših bolnikih, pri bolnikih z že obstoječimi boleznimi centralnega živčnega sistema (CŽS) (npr. lezije v možganih ali epileptični napadi v anamnezi) in/ali oslabljeno ledvično funkcijo.
English: Treatment was discontinued due to adverse reactions in 1.3 % of patients.
Slovenian: Zdravljenje so zaradi neželenih učinkov prekinili pri 1,3 % bolnikov.
English: In the absence of severe renal impairment, no dosage adjustment is necessary in elderly patients.
Slovenian: Če bolnik nima hude okvare ledvic, prilagoditev odmerjanja pri starejših ni potrebna.
English: In vitro studies indicate that the effect of ertapenem on the plasma protein binding of highly protein bound medicinal products (warfarin, ethinyl estradiol, and norethindrone) was small.
Slovenian: V študijah in vitro je bil vpliv ertapenema na vezavo zdravil, ki se močno vežejo na plazemske beljakovine (varfarin, etinilestradiol in noretindron), majhen.
English: The prescribers are informed that local MIC breakpoints, if available, should be consulted.
Slovenian: Zdravniki morajo upoštevati lokalne referenčne vrednosti MIK, če so na voljo.
English: Side effects reported (frequency not known) since the drug has been marketed are:
Slovenian: Neželeni učinki (pogostnost neznana), o katerih so poročali med trženjem zdravila so:
English: Of the 80 % recovered in urine, approximately 38 % is excreted as unchanged ertapenem and approximately 37 % as the ring-opened metabolite.
Slovenian: Od 80 %, izločenih v urinu, se izloči približno 38 % nespremenjenega ertapenema, približno 37 % pa presnovka z odprtim obročem.
English: Gender The plasma concentrations of ertapenem are comparable in men and women.
Slovenian: Spol Plazemske koncentracije ertapenema so pri moških in ženskah primerljive.
English: Uncommon: Headache Not known: Hallucinations
Slovenian: Občasni: glavobol Neznana: halucinacije
English: INVANZ may influence patients' ability to drive and use machines.
Slovenian: Zdravilo INVANZ lahko vpliva na bolnikovo sposobnost vožnje in upravljanja s stroji.
English: For instructions on preparation of the medicinal product before administration, see section 6.6.
Slovenian: Za navodila glede priprave zdravila pred dajanjem glejte poglavje 6.6.